D-1340-2019 Class II Terminated
FDA drug recall D-1340-2019 was initiated by Glenmark Pharmaceuticals Inc., USA on Jun 3, 2019 and is designated Class II. Reason for recall: Defective Delivery System: Estradiol Vaginal Inserts USP plunger is not functioning properly. The recall status is terminated (terminated May 2, 2022). Affected quantity: 31,656 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 19, 2019
- Initiation Date
- Jun 3, 2019
- Termination Date
- May 2, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31,656 boxes
Product description
Estradiol Vaginal Inserts USP 10 mcg, packaged in box of 8 Vaginal Inserts (with disposable applicators), Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403 513 India, Manufactured for: Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430 USA, NDC 68462-711-71
Reason for recall
Defective Delivery System: Estradiol Vaginal Inserts USP plunger is not functioning properly.
Distribution pattern
U.S.A. Nationwide
Code information
Lot#: 20180516, Exp 4/30/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1340-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026